Endogenous Protease Inhibitors in Airway Epithelial Cells Contribute to Eosinophilic Chronic Rhinosinusitis

• Published in: American journal of respiratory and critical care medicine Vol. 195; no. 6; pp. 737 - 747
• Main Authors: Kouzaki, Hideaki, Matsumoto, Koji, Kikuoka, Hirotaka, Kato, Tomohisa, Tojima, Ichiro, Shimizu, Shino, Kita, Hirohito, Shimizu, Takeshi
• Format: Journal Article
• Language: English
• Published: United States American Thoracic Society 15.03.2017
• Subjects: Adult; Aged; Animals; Chronic Disease; Cystatin A - metabolism; Eosinophilia - complications; Eosinophilia - metabolism; Epithelial Cells - metabolism; Female; Humans; Interleukin-17 - metabolism; Interleukin-33 - metabolism; Male; Mice; Mice, Inbred BALB C; Middle Aged; Nasal Mucosa - metabolism; Original; Protease Inhibitors - metabolism; Proteinase Inhibitory Proteins, Secretory - metabolism; Rhinitis - complications; Rhinitis - metabolism; Serine Peptidase Inhibitor Kazal-Type 5; Sinusitis - complications; Sinusitis - metabolism; cytokine; protease; chronic rhinosinusitis; epithelial cell; endogenous protease inhibitor
• ISSN: 1073-449X; 1535-4970; 1535-4970
• DOI: 10.1164/rccm.201603-0529OC

Cystatin A and SPINK5 are endogenous protease inhibitors (EPIs) that may play key roles in epithelial barrier function. To investigate the roles of EPIs in the pathogenesis of chronic rhinosinusitis (CRS). We examined the expression of cystatin A and SPINK5 in the nasal epithelial cells of patients with CRS. Additionally, the in vitro effects of recombinant EPIs on the secretion of the epithelial-derived cytokines IL-25, IL-33, and thymic stromal lymphopoietin in airway epithelial cells, and the in vivo effects of recombinant EPIs in the nasal epithelium of mice exposed to multiple airborne allergens (MAA) were examined. Compared with control subjects and patients with noneosinophilic CRS, patients with eosinophilic CRS showed significantly lower protein and mRNA expression of cystatin A and SPINK5 in the nasal epithelium. Allergen-induced production of IL-25, IL-33, and thymic stromal lymphopoietin in normal human bronchial epithelial cells was inhibited by treatment with recombinant cystatin A or SPINK5. Conversely, the production of these cytokines was increased when cystatin A or SPINK5 were knocked down with small interfering RNA. Chronic MAA exposure induced goblet cell metaplasia and epithelial disruption in mouse nasal epithelium and decreased the tissue expression and nasal lavage levels of cystatin A and SPINK5. Intranasal instillations of recombinant EPIs attenuated this MAA-induced pathology. Cystatin A and SPINK5 play an important role in protecting the airway epithelium from exogenous proteases. The preservation of EPIs may have a therapeutic benefit in intractable airway inflammation, such as eosinophilic CRS.